DuneX Biosciences

DuneX Biosciences is a private, early-stage CRO offering specialized research services in functional genomics and antibody discovery. Its core technology platform integrates CRISPR screening, yeast display, and non-viral stable cell line engineering to deliver high-quality data and rapid turnaround for client R&D programs. Positioned in the competitive but growing biotech services sector, DuneX differentiates itself through its technical expertise and focus on innovative, non-viral methods. The company is likely pre-revenue or early-revenue, serving as a strategic partner for drug developers seeking to outsource complex discovery-stage biology.

Integrated platform combining CRISPR functional genomics screening, yeast display antibody discovery, and non-viral stable cell line engineering using the Sleeping Beauty transposon system.

DuneX competes in the fragmented drug discovery CRO market. It differentiates through its integrated offering of CRISPR screens, yeast display, and proprietary non-viral cell engineering. Key competitors include large players like Charles River Discovery Services and niche genomics/antibody discovery shops such as Horizon Discovery (CRISPR), Distributed Bio (yeast display), and various stable cell line specialists.